Autologous blood products, such as platelet-rich plasma (PRP), are gaining increasing
interest in different fields of regenerative medicine. Although growth factors, the main …

Platelet-Rich Plasma (PRP) is enriched in molecular messengers with restorative effects on
altered tissue environments. Upon activation, platelets release a plethora of growth factors …

Extracellular vesicles (EVs) are a newly-discovered way by which cells communicate with
their neighbors, as well as transporting cargos which once were considered to be limited by …

Despite the popularity of platelet-rich plasma (PRP) and platelet lysate (PL) in orthopaedic
practice, the mechanism of action and the effectiveness of these therapeutic tools are still …

There is much interest in the use of extracellular vesicles (EVs) as a subcellular therapy for
regenerative medicine and drug delivery. Blood-borne platelets represent a source of …

Extracellular vesicles (EVs) present a great potential for the development of new treatments
in the biomedical field. To be used as therapeutics, many different sources have been used …

Abstract Platelet‐rich plasma (PRP), due to its promising therapeutic properties, has been
used in regenerative medicine for more than 30 years and numerous encouraging outcomes …

EVs are membranous subcellular structures originating from various cells, including
platelets which consist of biomolecules that can modify the target cell's pathophysiological …

The use of platelet-rich plasma (PRP) has gained increasing interest in recent decades. The
platelet secretome contains a multitude of growth factors, cytokines, chemokines, and other …

Background Platelet-derived extracellular vesicles (EVs) participate, for example, in
haemostasis, immunity and development. Most studies of platelet EVs have targeted …